Seth Klarman’s Kindred Biosciences, Inc. KIN Stock Holding History

Seth Klarman’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,011,584	Closed	-$15M	–	49
2016 Q3	$15M	Sell	3,011,584 -2,264	-0.1%	-$9.57K	0.21%	37
2016 Q2	$10.7M	Hold	3,013,848	–	–	0.14%	35
2016 Q1	$10.4M	Hold	3,013,848	–	–	0.15%	31
2015 Q4	$10.2M	Hold	3,013,848	–	–	0.19%	32
2015 Q3	$15.7M	Hold	3,013,848	–	–	0.26%	34
2015 Q2	$20.6M	Hold	3,013,848	–	–	0.34%	27
2015 Q1	$21.5M	Hold	3,013,848	–	–	0.36%	25
2014 Q4	$22.5M	Hold	3,013,848	–	–	0.44%	23
2014 Q3	$27.9M	Buy	3,013,848 +250,000	+9%	+$3.38M	0.49%	20
2014 Q2	$51.5M	Hold	2,763,848	–	–	0.84%	17
2014 Q1	$51.2M	Sell	2,763,848 -136,152	-5%	-$2.6M	1.24%	14
2013 Q4	$32.4M	Buy	+2,900,000	New	+$34.6M	0.92%	13

Other funds holding KIN

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Seth Klarman's KIN Position: Q4 2016 in Review

Seth Klarman sold out of Kindred Biosciences, Inc. (KIN) in Q4 2016, closing a stake of 3,011,584 shares — an estimated $15M sold.

Seth Klarman first reported a position in KIN in Q4 2013 and held it in 12 quarters. The position peaked at $51.5M in Q2 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

Seth Klarman reported no remaining Kindred Biosciences, Inc. position as of Q4 2016 after selling out during the quarter.
Seth Klarman sold 3,011,584 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $15M.
Seth Klarman first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 12 quarters.
Seth Klarman's Kindred Biosciences, Inc. position peaked at $51.5M in Q2 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on Baupost Group's 13F filing for Q4 2016, filed 14 Feb 2017.